BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23420592)

  • 1. The selective therapeutic apheresis procedures.
    Sanchez AP; Cunard R; Ward DM
    J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG
    Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of blood purification techniques.
    Stegmayr BG
    Transfus Apher Sci; 2005 Apr; 32(2):209-20. PubMed ID: 15784456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic apheresis instrumentation.
    Wehrli G
    J Clin Apher; 2011; 26(5):286-90. PubMed ID: 21882232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
    Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
    J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
    Gülle S; Bak M; Serdaroglu E; Can D; Karabay O
    Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric therapeutic apheresis: rationale and indications for plasmapheresis, cytapheresis, extracorporeal photopheresis, and LDL apheresis.
    Kim YA; Sloan SR
    Pediatr Clin North Am; 2013 Dec; 60(6):1569-80. PubMed ID: 24237988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hemapheresis as of 2000.
    Valbonesi M; Bruni R; De Luigi MC
    Vox Sang; 2000; 78 Suppl 2():51-6. PubMed ID: 10938927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of long-term lipid apheresis at a single center.
    Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
    Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in therapeutic apheresis.
    Bosch T
    J Artif Organs; 2003; 6(1):1-8. PubMed ID: 14598117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
    Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
    Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology.
    Passalacqua S; Staffolani E; Busnach G; Roccatello D; Pasquali S; Cappelli P; Liuzzo G;
    J Clin Apher; 2005 Jul; 20(2):101-6. PubMed ID: 15880354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of currently available low-density lipoprotein apheresis systems.
    Matsuda Y; Malchesky PS; Nosé Y
    Artif Organs; 1994 Jan; 18(1):93-9. PubMed ID: 8141663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apheresis practice patterns in the United States of America: Analysis of a market claims database.
    Zantek ND; Martinez RJ; Johnson AD; Tholkes AJ; Shah S
    J Clin Apher; 2021 Oct; 36(5):750-758. PubMed ID: 34252989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid apheresis, indications, and principles.
    Winters JL
    J Clin Apher; 2011; 26(5):269-75. PubMed ID: 21834078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different lipoprotein apheresis methods on serum protein levels.
    Julius U; Siegert G; Kostka H; Schatz U; Hohenstein B
    Atheroscler Suppl; 2015 May; 18():95-102. PubMed ID: 25936311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.